Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
D000230:Adenocarcinoma / Q000276:immunology; D000368:Aged; D000937:Antigen-Antibody Reactions; D000961:Antilymphocyte Serum; D001803:Blood Transfusion; D001943:Breast Neoplasms / Q000276:immunology; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D002460:Cell Line; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005334:Fever; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology; D007964:Leukocytosis; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008722:Methods; D009362:Neoplasm Metastasis; D009447:Neuroblastoma / Q000276:immunology; D011392:Proline; D014316:Tritium; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000473:pathology; D014565:Urogenital Neoplasms / Q000276:immunology
D000961:Antilymphocyte Serum; D014316:Tritium; D011392:Proline